|
Market Closed -
Nasdaq
16:00:00 2026-10-27 EDT
|
5-day change | 1st Jan Change | ||
| 1.780 USD | -1.11% |
|
-3.97% | +10.76% |
| 10-15 | Mayne Pharma Group Resolves US Patent Litigation With Teva Pharmaceuticals; Shares Gain 3% | MT |
| 08-25 | TherapeuticsMD, Inc. Evaluates Strategic Alternatives | CI |
| Market Cap | 20.83M 18.7M 17.27M 15.66M 29.26M 1.98B 29.62M 207M 82.21M 1.04B 78.2M 76.53M 3.29B | P/E 2024 |
-4.55x | P/E 2025 | -30.9x |
|---|---|---|---|---|---|
| Enterprise Value | 19.45M 17.45M 16.12M 14.61M 27.32M 1.85B 27.65M 193M 76.74M 968M 73M 71.44M 3.07B | EV / Sales 2024 |
6.83x | EV / Sales 2025 | 5.78x |
| Free-Float |
90.96% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TXMD | Delayed | |
CBOE
| TXMD | Real-time | |
Deutsche Boerse AG
| 29TA | Delayed | |
Börse Stuttgart
| 29TA | Delayed | |
Boerse Muenchen
| 29TA | Real-time |
| 1 day | +0.30% | ||
| 1 week | -3.97% | ||
| Current month | -11.06% | ||
| 1 month | -13.62% | ||
| 3 months | -12.78% | ||
| 6 months | -12.78% | ||
| Current year | +10.76% |
| 1 week | 1.76 | 1.91 | |
| 1 month | 1.75 | 2.12 | |
| Current year | 1.58 | 2.95 | |
| 1 year | 1.11 | 2.95 | |
| 3 years | 0.7 | 3.07 | |
| 5 years | 0.7 | 39.7 | |
| 10 years | 0.7 | 414.76 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marlan Walker
CEO | Chief Executive Officer | 51 | 2022-12-29 |
Joseph Ziegler
DFI | Director of Finance/CFO | 52 | 2023-08-16 |
| Director | Title | Age | Since |
|---|---|---|---|
Cooper Collins
BRD | Director/Board Member | 46 | 2012-02-28 |
Tommy Thompson
CHM | Chairman | 83 | 2012-04-15 |
Gail Naughton
BRD | Director/Board Member | 69 | 2020-03-19 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 12/23/25 | Buy | Chairman | 8,400 | 0.0726% | ||
| 11/3/25 | Free | Chairman | 8,500 | 0.0734% | ||
| 11/3/25 | Free | Director | 8,500 | 0.0734% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.11% | -3.97% | +37.82% | -10.18% | 20.83M | ||
| +0.22% | -0.11% | +55.16% | +128.89% | 1,140B | ||
| +0.91% | +3.62% | +41.23% | +84.59% | 641B | ||
| -0.10% | -0.91% | +25.62% | +106.18% | 507B | ||
| +0.63% | +2.33% | +49.21% | +67.82% | 383B | ||
| +0.86% | -4.38% | +61.14% | +37.92% | 347B | ||
| +1.02% | +1.80% | +24.84% | +53.75% | 293B | ||
| -0.25% | +1.62% | +2.20% | +26.65% | 266B | ||
| +0.75% | +2.07% | +53.87% | +71.28% | 240B | ||
| +0.25% | +1.63% | +32.03% | +107.60% | 197B | ||
| Average | +0.28% | +2.31% | +38.31% | +67.45% | 401.38B | |
| Weighted average by Cap. | +0.35% | +2.98% | +42.22% | +88.50% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.76M 1.58M 1.46M 1.32M 2.47M 167M 2.5M 17.5M 6.95M 87.68M 6.61M 6.47M 278M | 3.02M 2.71M 2.5M 2.27M 4.24M 287M 4.3M 30.03M 11.92M 150M 11.34M 11.1M 477M |
| Net income | -2.18M -1.96M -1.81M -1.64M -3.06M -207M -3.1M -21.67M -8.61M -109M -8.19M -8.01M -344M | -569K -511K -472K -428K -799K -54.05M -809K -5.65M -2.25M -28.33M -2.14M -2.09M -89.84M |
| Net Debt | 2.12M 1.9M 1.75M 1.59M 2.97M 201M 3.01M 21.02M 8.35M 105M 7.94M 7.77M 334M | -1.39M -1.24M -1.15M -1.04M -1.95M -132M -1.97M -13.77M -5.47M -69.01M -5.2M -5.09M -219M |
Employees
1
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-27 | US$1.780 | -1.11% | 7,103 |
| 26-10-26 | US$1.800 | 0.00% | 6,387 |
| 26-10-23 | US$1.800 | -2.70% | 15,707 |
| 26-10-22 | US$1.850 | -2.63% | 5,654 |
| 26-10-21 | US$1.900 | +1.06% | 6,504 |
- Stock Market
- Stocks
- TXMD Stock
Select your edition
All financial news and data tailored to specific country editions

















